Join our growing community to challenge mainstream media bias and fix the news
Moderna to begin clinical trials of COVID booster shots

Moderna to begin clinical trials of COVID booster shots

Doses of a new COVID-19 vaccine which has been designed to provide better protection against a variant of the virus from South Africa has been shipped to the NIH by Moderna. The current two-dose regimen generates a weaker immune response according to Moderna to the strain generated in South Africa. Antibodies still remain above the expected levels to protect against the virus according to Moderna.

Sandra
Sandra
Top in World